Last update 07 Sep 2023
BioXyTran, Inc.

BioXyTran, Inc.

Public Company|
2008|
Massachusetts, United States|
OTC: BIXT

Overview

Tags

Nervous System Diseases
Respiratory Diseases
Cardiovascular Diseases
Protein drugs
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Protein drugs2
Small molecule drug1
Top 5 TargetCount
galectin-1(Galectin-1)1

Pipeline

Pipeline Snapshot as of 24 Sep 2023

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 3 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ProLectin Rx
( galectin-1 )
COVID-19
More
Phase 3 Clinical
BXT-25
Stroke
More
Preclinical
BXT-252
Wounds and Injuries
More
Preclinical
Login to view more data

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.